SCHEMBL2367722

SCHEMBL2367722

COc1ccc(C(OCc2cc(CO)cc(-c3cccc4ccccc34)c2)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.43
PPARA Q07869 9/20 0.43
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PPARD Q03181 1/20 0.41
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 2/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 1/20 0.36
GPR84 Q9NQS5 1/20 0.36
ABL1 P00519 1/20 0.36
ABCB1 P08183 1/20 0.36
BCR P11274 1/20 0.36
BACE1 P56817 1/20 0.36
ACACA Q13085 1/20 0.36
AKR1B1 P15121 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368004 0.95 PPARG (0.39) PPARGPPARACYP2C9CYP2C19PPARD
SCHEMBL2367752 0.89 PPARG (0.34) PPARGPPARACYP2C9CYP2C19PPARD
SCHEMBL2367340 0.88 BACE1 (0.33) PPARGPPARAPPARDMAPTGPR84
SCHEMBL2367563 0.84 BACE1 (0.42) PPARGPPARDKDM4EALDH1A1MAPT
SCHEMBL12539335 0.81 RAB9A (0.43)
SCHEMBL19689391 0.80 KIF11 (0.38) HTTLMNA
SCHEMBL16618219 0.80 CYP1A2 (0.38) CYP2C19HTTBACE1LMNA
SCHEMBL19463046 0.80 KIF11 (0.43)
SCHEMBL16618237 0.78 MAOB (0.47) PPARDMAPT
SCHEMBL16624846 0.77 BACE1 (0.42) PPARDABL1ABCB1BCRBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366785-B1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT, AND USE OF THE LABELING AGENT JAPAN SCIENCE & TECH AGENCY (JP) 2013-01-16 EP disclosed
US-8354515-B2 Oligonucleotide derivative, labeling agent and use for labeling agent JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2013-01-15 US disclosed
US-20120126175-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT AND USE FOR LABELING AGENT JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2012-05-24 US disclosed
EP-2366785-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT, AND USE OF THE LABELING AGENT Japan Science And Technology Agency (JP) 2011-09-21 EP disclosed
WO-2010055789-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT, AND USE OF THE LABELING AGENT 独立行政法人科学技術振興機構 (JP) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120126175-A1 OLIGONUCLEOTIDE DERIVATIVE, LABELING AGENT AND USE FOR LABELING AGENT UPF1, SPIN4, SRRT PPARG 1343/4885PPARA 1658/4885CYP2C9 2619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.